Created in 1945 as a pharmaceutical company, Diagnostica Stago is now a world leader in the In-Vitro Diagnostics industry. Global, privately-owned and independent, Stago is fully dedicated to the exploration of Thrombosis and Haemostasis.

Day in and day out, Stago is committed to enhancing the quality of healthcare by offering laboratories advanced testing systems and superior services, the fruit of their expertise and know-how in Haemostasis (reagents, instruments and disposables).

Distributed in over 110 countries through a network of subsidiaries and exclusive distributors, Stago is in a position to guarantee customers superior service and a product portfolio meeting the demands of global healthcare systems. Today, 90% of their production, developed and made in France, is exported.

Specialising in the field of coagulation for over 60 years, Stago has acquired solid industrial experience (R&D, standardisation and production) in the field of In Vitro Diagnostics and lasting recognition from the scientific community.

The field of biomedical science is constantly evolving and expanding; new discoveries are moving medicine increasingly towards individual treatments that require diagnostic markers and ever more precise exploratory tools. These are their challenges of tomorrow.

Stago, relying on strong human and technological potential, promises much to contribute in the years to come.